| Pharmaceutical active ingredients: |
| Mepivacaine Hydrochloride |
| Available forms, composition and doses of Arestocaine: |
| Injectable; Injection; Mepivacaine Hydrochloride 3% |
| Arestocaine medical category: |
| Human:Local anesthetics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N01BB03 - Mepivacaine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| SolvayCarlisle Laboratories |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Arepanrix H1N1 | Haemagglutinin A / Californina / 7 / 2009 (H1N1) V-Like Strain (X-179A); Polysorbate 80; Squalene; Vitamin E (DL-Alpha Tocopherol) | ID Biomedical Corporation |
| Aresol | Guaifenesin | Unidentified Pharmaceutical Company |
| Arestal | Loperamide Oxyde Monohydrate | Janssen; Norgine |
| Arestin | Minocycline Hydrochloride | OraPharma; Cord Logistics |
| Arestin Microspheres | Minocycline Hydrochloride | OraPharma; Johnson & Johnson |
| Arestocaine with Levonordefrin | Levonordefrin Hydrochloride; Mepivacaine Hydrochloride | Solvay; Carlisle Laboratories |
| A-Ret | Tretinoin | Shalaks Pharmaceuticals |
| A-Ret HC | Hydrocortisone; Hydrocortisone Acetate; Hydroquinone; Tretinoin | Shalaks Pharmaceuticals |
| Aretensin | Piretanide; Ramipril | Sanofi-Aventis; Takeda Pharmaceutical |
| A-Ret-TZ | Tazarotene | Shalaks Pharmaceuticals |